Skip to main content

2023 ACCP Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Title

Browse by Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

F
Faculty Panel Discussion: Panel Discussion: Are Mechanistic Models Necessary or Nice-to-Have in the Development of Multispecific Antibodies? (9)
Favorite

9
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (3)
Favorite

3
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (4)
Favorite

4
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (6)
Favorite

6
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (7)
Favorite

7
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (4)
Favorite

4
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (4)
Favorite

4
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (4)
Favorite

4
Faculty Panel Discussion, Questions & Answers, Learner Feedback & Evaluation (5)
Favorite

5
First-in-Human Dose Selection of Immune-activating Biotherapeutics in Oncology (2)
Favorite

Haleh Saber, PhD (she/her/hers) – US Food & Drug Administration ### 1827465###Faculty###Hematology Oncology Toxicology, Office of Oncologic Diseases, Ctr for Drug Evaluation & Research###US Food & Drug Administration###
Faculty: Haleh Saber, PhD (she/her/hers) – US Food & Drug Administration
### she/her/hers 2
First-in-Patient Dose Prediction for Adeno-associated, Virus-mediated Gene Therapy (2)
Favorite

Peng Zou, PhD – Daiichi Sankyo Co Ltd ### 1827473###Co-Chair & Faculty###Director, Quantitative Clinical Pharmacology###Daiichi Sankyo Co Ltd###
Co-Chair & Faculty: Peng Zou, PhD – Daiichi Sankyo Co Ltd
### 2
Food Effect Assessment in Pediatrics: A Few Considerations (2)
Favorite

Vikram Arya, PhD – US Food & Drug Administration ### 637866###Faculty###Associate Director, Therapeutic Review, Div of Infectious Disease Pharmacology, Office of Clinical Pharmacology###US Food & Drug Administration###
Faculty: Vikram Arya, PhD – US Food & Drug Administration
### 2
Food: Leveraging the Clinical Pharmacology of Your Oncology Drug (3)
Favorite

Brian Booth, PhD – US Food & Drug Administration ### 1156385###Faculty###Director, Office of Clinical Pharmacology, CDER###US Food & Drug Administration###
Faculty: Brian Booth, PhD – US Food & Drug Administration
### 3
Formulation Considerations to Support Dosing of Drugs via Feeding Tubes & With Soft Foods (3)
Favorite

Karen Thompson, PhD – Merck & Co ### 1827481###Faculty###Senior Principal Scientist, Preclinical Development###Merck & Co###
Faculty: Karen Thompson, PhD – Merck & Co
### 3